Summary
This Lancet Diabetes & Endocrinology commission, authored by a large international expert panel convened under the auspices of Rubino and colleagues, proposes a formal definition and set of diagnostic criteria for clinical obesity. The work likely distinguishes clinical obesity — characterised by measurable impairment of bodily function or organ systems — from preclinical excess adiposity, challenging the sole reliance on BMI thresholds. The paper represents a significant attempt to reframe obesity as a chronic disease with objective clinical criteria, with implications for diagnosis, treatment eligibility, and health policy.
UK applicability
The framework is directly applicable to UK clinical practice and NHS obesity pathways, and is likely to inform NICE guidance updates; UK co-authors (including Batterham RL and Farooqi IS) ensure that UK epidemiological and healthcare contexts are represented within the commission.
Key measures
Diagnostic criteria for clinical obesity; anthropometric measures (e.g. BMI, waist circumference); functional and organ-specific health impairments; disease staging or severity classification
Outcomes reported
The paper proposes and defines formal diagnostic criteria for clinical obesity, distinguishing it from excess adiposity alone. It likely reports on clinical indicators, staging frameworks, and measurable health impairments used to confirm a diagnosis of clinical obesity.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.